It is rare that one has the opportunity to be involved with a company that is setting the industry on fire. I am eager and excited to carry the innovation torch globally to bring personalized skincare to physicians and their patients.
PHOENIX (PRWEB) September 17, 2020
In an unprecedented timeline, Aesthetics Biomedical® Inc. (ABM) consistently meets the increasing demand for its’ revolutionary aesthetic products and the resulting distribution needs. Most recently, in the company’s ongoing corporate expansion efforts, ABM has recruited industry expert Joe Willis in the role of Vice President of Commercialization.
In his new role, Joe Willis will oversee ABM’s novel skincare line, SoME® Skincare which is the first of its kind autologous topical skincare product with proven results. The personalized topical take-home treatment, SoME® Skincare + PRP, is an anti-aging skin rejuvenating treatment to reduce the appearance of fine lines and wrinkles, discoloration, puffiness, darkness around the eyes, and enhance skin tone and texture. As Vice President of Commercialization, Joe Willis will play a pivotal role in the company’s expansion and international distribution of the SoME® Skincare line in 2021; facilitating acceleration of several products currently under development that incorporate ABM’s proprietary BioLyte-5 technology for truly personalized skincare, for everyone.
“I am thrilled to join the ABM family, an organization built on integrity and innovation. ABM clearly demonstrates their proven scientific capabilities with novel innovations like the SoME® Skincare platform, a real first of its kind skin treatment technology,” says Joe Willis. He continues, “It is rare that one has the opportunity to be involved with a company that is setting the industry on fire. I am eager and excited to carry the innovation torch globally to bring personalized skincare to physicians and their patients. “
Aesthetics Biomedical® CEO & President MaryAnn Guerra accentuates the entire company’s sentiments stating, “With Joe at the helm of the SoME® Skincare strategy and distribution, ABM as an entity will undoubtedly benefit through an increase in SoME® Skincare sales capacity, both domestically and internationally, but also from the leadership and formidable expertise he brings to our already unmatched team of brilliant innovators.”
Joe Willis brings over 25 years of leadership and highly respected aesthetic industry experience to Aesthetics Biomedical®. He has a proven record of leadership success in General Management, Business Development, Sales and Marketing positions with leading healthcare corporations. Joe also has vast experience working with start-up companies to maximize and accelerate their growth and success.
Aesthetics Biomedical®, having achieved initial success by launching the Vivace® and Vivace Experience® in the US, the most well-known RF microneedling treatment device in the industry, is set to break records and pioneer the aesthetic industry for years to come with the expansion of its innovative product offerings and the impressive team that makes it all happen.
ABOUT AESTHETICS BIOMEDICAL®: Aesthetics Biomedical® Inc., headquartered in Phoenix, Ariz., is committed to the development and distribution of novel aesthetic devices, products, and services in the global market. Aesthetics Biomedical’s innovation center is a leader in breakthrough technologies and combination therapies for its clients, physician network and the aesthetic arena, creating novel patient treatment experiences that benefit from ongoing research, approved clinical indications for use, as well as a personalized approach designed for consumer benefit. For more information, please visit AestheticsBiomedical.com.